Uterine Cancer Therapeutics market report by 2021 Uterine Cancer Therapeutics market report by 2021 | Page 4

TABLE OF CONTENTS
1. Introduction 1.1 Market Definition 1.2 Study Deliverables 1.3 Base Currency, Base Year and Forecast Periods 1.4 General Study Assumptions 2. Research Methodology
3. Overview
2.1 Introduction 2.2 Research Phases
2.3 Analysis Design 2.4 Study Timeline
2.2.1 Secondary Research 2.2.2 Primary Research 2.2.3 Econometric Modelling 2.2.4 Expert Validation
3.1 Executive Summary 3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis( DROC)
4.1 Market Drivers 4.2 Market Restraints 4.3 Key Challenges 4.4 Current Opportunities in the Market
5. Market Segmentation 5.1 By Type
5.2 By Therapy
5.1.1 Endometrial Carcinoma 5.1.2.1 Adenocarcinoma 5.1.2.2 Carcinosarcoma 5.1.2.3 Squamous cell carcinoma 5.1.2.4 Others
5.1.2 Uterine Sarcoma